Informações:
Falhas:
ID
26628
Descrição
Anastrozole or Fulvestrant in Treating Postmenopausal Patients With Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00871858
Link
https://clinicaltrials.gov/show/NCT00871858
Palavras-chave
Versões (1)
- 22/10/2017 22/10/2017 -
Titular dos direitos
See clinicaltrials.gov
Transferido a
22 de outubro de 2017
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility Breast Cancer NCT00871858
Eligibility Breast Cancer NCT00871858
- StudyEvent: Eligibility
Similar models
Eligibility Breast Cancer NCT00871858
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Invasive carcinoma of breast
Item
histologically confirmed invasive breast cancer, meeting 1 of the following criteria:
boolean
C0853879 (UMLS CUI [1])
Disease Scarff-Bloom-Richardson Grading System | Age
Item
sbr grade i-ii disease (patients < 65 years of age)
boolean
C0012634 (UMLS CUI [1,1])
C3828224 (UMLS CUI [1,2])
C0001779 (UMLS CUI [2])
C3828224 (UMLS CUI [1,2])
C0001779 (UMLS CUI [2])
Disease Scarff-Bloom-Richardson Grading System | Age
Item
sbr grade i-iii disease (patients > 65 years of age)
boolean
C0012634 (UMLS CUI [1,1])
C3828224 (UMLS CUI [1,2])
C0001779 (UMLS CUI [2])
C3828224 (UMLS CUI [1,2])
C0001779 (UMLS CUI [2])
Disease TNM Breast tumor staging
Item
t2 (2-5 cm), t3, or t4b, and n0-1 disease
boolean
C0012634 (UMLS CUI [1,1])
C0474926 (UMLS CUI [1,2])
C0474926 (UMLS CUI [1,2])
Neoplasm Metastasis Excluded
Item
no metastatic disease
boolean
C0027627 (UMLS CUI [1,1])
C2828389 (UMLS CUI [1,2])
C2828389 (UMLS CUI [1,2])
Lesion of breast | Breast-Conserving Surgery Unsuccessful
Item
breast lesion not amenable to breast-conserving resection
boolean
C0567489 (UMLS CUI [1])
C0917927 (UMLS CUI [2,1])
C1272705 (UMLS CUI [2,2])
C0917927 (UMLS CUI [2,1])
C1272705 (UMLS CUI [2,2])
Inflammatory Breast Carcinoma Excluded
Item
no inflammatory breast cancer
boolean
C0278601 (UMLS CUI [1,1])
C2828389 (UMLS CUI [1,2])
C2828389 (UMLS CUI [1,2])
Breast Carcinoma Previous Excluded
Item
no prior breast cancer
boolean
C0678222 (UMLS CUI [1,1])
C0205156 (UMLS CUI [1,2])
C2828389 (UMLS CUI [1,3])
C0205156 (UMLS CUI [1,2])
C2828389 (UMLS CUI [1,3])
Hormone Receptor Status
Item
hormone receptor status:
boolean
C0019929 (UMLS CUI [1,1])
C0449438 (UMLS CUI [1,2])
C0449438 (UMLS CUI [1,2])
Estrogen receptor positive | Progesterone receptor positive
Item
estrogen receptor- and/or progesterone receptor-positive
boolean
C0279754 (UMLS CUI [1])
C0279759 (UMLS CUI [2])
C0279759 (UMLS CUI [2])
Client Characteristics
Item
patient characteristics:
boolean
C0815172 (UMLS CUI [1])
Postmenopausal state
Item
postmenopausal
boolean
C0232970 (UMLS CUI [1])
Exclusion Cancer Other | Exception Skin carcinoma Treated | Exception Carcinoma in situ of uterine cervix Treated
Item
no other cancer within the past 5 years except for adequately treated skin carcinoma or carcinoma in situ of the cervix
boolean
C2828389 (UMLS CUI [1,1])
C1707251 (UMLS CUI [1,2])
C1705847 (UMLS CUI [2,1])
C0699893 (UMLS CUI [2,2])
C1522326 (UMLS CUI [2,3])
C1705847 (UMLS CUI [3,1])
C0851140 (UMLS CUI [3,2])
C1522326 (UMLS CUI [3,3])
C1707251 (UMLS CUI [1,2])
C1705847 (UMLS CUI [2,1])
C0699893 (UMLS CUI [2,2])
C1522326 (UMLS CUI [2,3])
C1705847 (UMLS CUI [3,1])
C0851140 (UMLS CUI [3,2])
C1522326 (UMLS CUI [3,3])
Exclusion Medical contraindication Hormone Therapy
Item
no contraindication to anti-hormonal treatment
boolean
C2828389 (UMLS CUI [1,1])
C1301624 (UMLS CUI [1,2])
C0279025 (UMLS CUI [1,3])
C1301624 (UMLS CUI [1,2])
C0279025 (UMLS CUI [1,3])
Exclusion Condition Preventing Follow-up
Item
no psychological, familial, social, or geographical reasons that would preclude follow up
boolean
C2828389 (UMLS CUI [1,1])
C0348080 (UMLS CUI [1,2])
C1292733 (UMLS CUI [1,3])
C3274571 (UMLS CUI [1,4])
C0348080 (UMLS CUI [1,2])
C1292733 (UMLS CUI [1,3])
C3274571 (UMLS CUI [1,4])
Therapeutic procedure
Item
prior concurrent therapy:
boolean
C0087111 (UMLS CUI [1])
Hormone replacement therapy
Item
at least 8 days since prior hormone replacement therapy
boolean
C0282402 (UMLS CUI [1])
Exclusion Therapeutic procedure Against Vitamin K
Item
no concurrent anti-vitamin k treatment
boolean
C2828389 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
C0521124 (UMLS CUI [1,3])
C0042878 (UMLS CUI [1,4])
C0087111 (UMLS CUI [1,2])
C0521124 (UMLS CUI [1,3])
C0042878 (UMLS CUI [1,4])